Variant report
Variant | esv1963217 |
---|---|
Chromosome Location | chr6:114647056-114647515 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146344781 | chr6:114647091-114647092 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113223876 | chr6:114647105-114647106 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs58800329 | chr6:114647127-114647128 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs546010489 | chr6:114647156-114647157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527964923 | chr6:114647162-114647163 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549729120 | chr6:114647202-114647203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561517349 | chr6:114647246-114647247 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs185566124 | chr6:114647254-114647255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550246438 | chr6:114647257-114647258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571609018 | chr6:114647274-114647275 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532063068 | chr6:114647282-114647283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532484088 | chr6:114647315-114647316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs796769 | chr6:114647321-114647322 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs565764411 | chr6:114647344-114647345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149990152 | chr6:114647350-114647351 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145390622 | chr6:114647409-114647410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567448821 | chr6:114647467-114647468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113945333 | chr6:114647502-114647503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144780708 | chr6:114647511-114647512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Acute myeloid leukemia | 19651600 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:114637600-114649600 | Weak transcription | Brain Substantia Nigra | brain |
2 | chr6:114637600-114652200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:114640400-114651000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:114643000-114649600 | Weak transcription | Brain Hippocampus Middle | brain |
5 | chr6:114644000-114648000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:114644400-114651600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr6:114645200-114649800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
8 | chr6:114645400-114652400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr6:114646000-114648400 | Weak transcription | H1 Cell Line | embryonic stem cell |
10 | chr6:114646000-114648400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr6:114646000-114648400 | Weak transcription | H9 Cell Line | embryonic stem cell |
12 | chr6:114646200-114647800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr6:114646200-114649800 | Weak transcription | Brain Angular Gyrus | brain |
14 | chr6:114646400-114647600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
15 | chr6:114646400-114648000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr6:114646600-114648000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
17 | chr6:114646600-114655400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
18 | chr6:114647000-114651600 | Enhancers | HUES6 Cell Line | embryonic stem cell |